Dawn M. Sievert
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 0.1%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Use and Resistance 10
-
- Antimicrobial Resistance in Staphylococcus 10
- Clostridium difficile and Clostridium perfringens research 2
- Co-authors
- Jonathan R. Edwards (8 shared papers)Jean Baldus Patel (5 shared papers)Scott K. Fridkin (7 shared papers)Daniel A. Pollock (5 shared papers)Alicia Hidrón (1 shared paper)Teresa C Horan (1 shared paper)Brandi M. Limbago (2 shared papers)Lindsey M. Weiner (3 shared papers)
- Journals
- Infection Control and Hospital Epidemiology (8 papers)American Journal of Infection Control (2 papers)Emerging infectious diseases (2 papers)Clinical Infectious Diseases (2 papers)American Journal of Public Health (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Dawn M. Sievert
27 papers receiving 8.2k citations
Dawn M. Sievert's Hit Papers
Peers
Comparison fields: 5 of 141
- Applied Microbiology and Biotechnology 864
- Molecular Medicine 2.0k
- Clinical Biochemistry 1.5k
- Critical Care and Intensive Care Medicine 858
- Infectious Diseases 3.3k
Countries citing papers authored by Dawn M. Sievert
This map shows the geographic impact of Dawn M. Sievert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn M. Sievert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn M. Sievert more than expected).
Fields of papers citing papers by Dawn M. Sievert
This network shows the impact of papers produced by Dawn M. Sievert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn M. Sievert. The network helps show where Dawn M. Sievert may publish in the future.
Co-authors
The 25 scholars most cited alongside Dawn M. Sievert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007 Hit paper breakdown → | 2008 | 3289 |
| 2 | Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010 Hit paper breakdown → | 2012 | 1341 |
| 3 | Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011–2014 Hit paper breakdown → | 2016 | 1049 |
| 4 | Infection with Vancomycin-ResistantStaphylococcus aureusContaining thevanAResistance Gene Hit paper breakdown → | 2003 | 931 |
| 5 | National Healthcare Safety Network (NHSN) report, data summary for 2012, Device-associated module Hit paper breakdown → | 2013 | 518 |
| 6 | 2008 | 400 | |
| 7 | 2006 | 310 | |
| 8 | National Healthcare Safety Network report, data summary for 2013, Device-associated Module Hit paper breakdown → | 2015 | 305 |
| 9 | 2021 | 144 | |
| 10 | 2017 | 132 | |
| 11 | 2012 | 49 | |
| 12 | 2018 | 46 | |
| 13 | 2011 | 37 | |
| 14 | 2023 | 28 | |
| 15 | Influenza vaccination performance measurement among acute care hospital-based health care personnel--United States, 2013-14 influenza season. | 2014 | 14 |
| 16 | 2025 | 14 | |
| 17 | 2015 | 12 | |
| 18 | 2011 | 8 | |
| 19 | 2015 | 7 | |
| 20 | 2021 | 7 |
About Dawn M. Sievert
Dawn M. Sievert is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases, Molecular Medicine, Clinical Biochemistry and Epidemiology, having authored 29 papers that have together received 8.7k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (10 papers), Antibiotic Use and Resistance (10 papers), Bacterial Identification and Susceptibility Testing (6 papers), Antibiotic Resistance in Bacteria (6 papers), Pneumonia and Respiratory Infections (4 papers), Nosocomial Infections in ICU (2 papers), Mycobacterium research and diagnosis (2 papers) and Clostridium difficile and Clostridium perfringens research (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (864 citations), Molecular Medicine (2.0k citations), Clinical Biochemistry (1.5k citations), Critical Care and Intensive Care Medicine (858 citations) and Infectious Diseases (3.3k citations). Dawn M. Sievert has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Jonathan R. Edwards, Jean Baldus Patel, Scott K. Fridkin, Daniel A. Pollock, Alicia Hidrón, Teresa C Horan, Brandi M. Limbago, Lindsey M. Weiner, Margaret A. Dudeck and Jeffrey C. Hageman. Their work appears in journals such as Infection Control and Hospital Epidemiology, American Journal of Infection Control, Emerging infectious diseases, Clinical Infectious Diseases and American Journal of Public Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.